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The PI3K/Akt signal transduction pathway is a well-known mediator of growth promoting and cell survival signals. While the expression
and function of this pathway have been documented during early and late stages of the reproductive process, currently, there is no evidence
demonstrating either the presence or function of the PI3K/Akt pathway in murine preimplantation embryos. We found, using confocal
immunofluorescent microscopy and Western blot analysis, that the p85 and p110 subunits of PI3K and Akt are expressed from the 1-cell
through the blastocyst stage of murine preimplantation embryo development. These proteins were localized predominantly at the cell surface
from the 1-cell through the morula stage. At a blastocyst stage, both PI3K and Akt exhibited an apical staining pattern in the trophectoderm
cells. Interestingly, phosphorylated Akt was detected throughout murine preimplantation development, and its presence at the plasma
membrane is a reflection of its activation status. Inhibition of Akt activity had significant effects on the normal physiology of the blastocyst.
Specifically, inhibition of this pathway resulted in a reduction in insulin-stimulated glucose uptake. In addition, inhibiting Akt activity
resulted in a significant delay in blastocyst hatching, a developmental step facilitating implantation. Finally, we established the presence of
this pathway in trophoblast stem (TS) cells, a potentially useful in vitro model to study this signaling cascade. Taken together, these data are
the first to demonstrate the presence and function of the PI3K/Akt pathway in mammalian preimplantation embryos.
D 2005 Elsevier Inc. All rights reserved.Keywords: PI3K/Akt; Preimplantation mouse embryo; Trophoblast stem; Blastocyst hatchingIntroduction
The mammalian preimplantation embryo is a critical and
unique stage in embryonic development. It is at this time
that a number of significant developmental milestones are
achieved, including the first mitotic divisions, the establish-
ment of cellular contacts and the differentiation of the first
cell lineages. The unique environment in which the
preimplantation embryo develops further characterizes this0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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1 These authors contributed equally to this manuscript.stage. At this time, the embryo is free-floating, having no
direct cell to cell contact, lacks a blood supply and is
exposed to a dynamic fluid environment (Hardy and
Spanos, 2002). The embryo is dependent on autocrine
and paracrine growth factors to support its growth and
development.
Four days post-fertilization (in the mouse), the embryo
has reached the blastocyst stage of development, the point in
embryonic development when the first cell differentiation
step has occurred. At this stage, the embryo is comprised of
the epithelial trophectoderm (TE), which is a layer of cells
that surrounds the embryo and will develop into the extra
embryonic tissue, and the inner cell mass (ICM), which
consists of the pluripotent cells that will later differentiate284 (2005) 377 – 386
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ment, and the maintenance of pregnancy that an effective
maternal–embryonic interface is established.
Prior to implantation, the developing embryo is depend-
ent on signals generated by growth factors present in the
maternal environment. These growth factors are known to
regulate cell proliferation and differentiation during mam-
malian preimplantation development (Raff, 1992; Weil et
al., 1996). Embryos are able to respond to these growth
factors because they express many of the cognate receptors
for the ligands present in the maternal tract and those
synthesized by the embryo itself (Dardik et al., 1992).
Although embryos are capable of developing in vitro, their
development is significantly delayed relative to develop-
ment in vivo, suggesting roles for both embryo- and
maternal-derived growth factors (Bowman and McLaren,
1970; Paria and Dey, 1990). This hypothesis is also
supported by the fact that culturing embryos at high density
or in the presence of specific growth factors can partially
reduce the developmental delay (Adamson, 1993). For
example, transforming growth factor-a (TGF-a), whose
cognate receptor is expressed from a 4-cell stage on, has
been shown to significantly enhance in vitro development
(Dardik et al., 1992; Paria and Dey, 1990; Rappolee et al.,
1988; Wiley et al., 1992).
During this preimplantation period, the embryo
expresses a number of receptors known to activate the
phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Speci-
fically, the IGF-1 and insulin receptors are expressed from
the 1-cell stage onward (Lighten et al., 1997; Smotrich et
al., 1996). Over the past decade, the PI3K/Akt cascade has
been extensively studied and implicated as a key regulator
of a number of cellular functions, including cellular
migration, mitogenesis, differentiation and cell survival
(Franke et al., 1997). Initially implicated in the suppression
of apoptosis in growth-factor-mediated survival of the
pheochromocytoma cell line PC12, PI3K activity was
subsequently found to be required for the growth-factor-
dependent survival of a wide variety of cell lines ranging
from fibroblasts to neurons (Crowder and Freeman, 1998;
Scheid et al., 1995; Stambolic et al., 1998; Vemuri and
McMorris, 1996; Yao and Cooper, 1995). Although a
number of molecular substrates for PI3K have been
identified, it is believed that Akt is the primary target
responsible for mediating an antiapoptotic signal. Akt is a
pivotal player in multiple cellular signaling pathways and
acts as a transducer of many functions initiated by growth
factor receptors that activate PI3K.
Akt, a serine threonine kinase, is the cellular homolog
of the transforming oncogene of the AKT8 retrovirus
(Staal, 1987). There are three known Akt family members
(Akt1–3) that are differentially expressed in a variety of
tissues (Bellacosa et al., 1993). Akt family members share
a common structure that consists of an N-terminal
regulatory pleckstrin homology (PH) domain, a hinge
region connecting the PH domain to a kinase domain withserine– threonine specificity, and a C-terminal region
required for the induction and maintenance of its kinase
activity (Ahmed et al., 1993; Chan et al., 1999; Franke
et al., 1994).
Although these family members are highly homologous,
the phenotypes of Akt1 and Akt2 deficient mice are distinct,
implying that these proteins have separate physiological
roles. Akt1 knockout mice are growth-retarded and exhibit
increased levels of apoptosis, but they do not have
metabolic defects (Chen et al., 2001; Cho et al., 2001b).
In contrast, Akt2 knockout mice are insulin resistant and
display a diabetic phenotype (Cho et al., 2001a). A
deficiency in both Akt1 and Akt2 results in perinatal
lethality. These mice are extremely growth-retarded, they
exhibit atrophy in multiple organ systems and display failed
adipogenesis (Peng et al., 2003). Thus, even though Akt
isoforms are activated similarly and phosphorylate down-
stream substrates with equal specificity and efficiency
(Franke, 2000), the aforementioned data suggest that these
kinases have distinct biological roles, namely, Akt1 is
involved in the transduction of growth signals, while Akt2 is
critical for glucose homeostasis.
Although PI3K and Akt expression have not been
characterized in mammalian preimplantation embryos, the
expression and function of these kinases have been explored
in the reproductive system of animals at times other than
preimplantation embryo development. Studies conducted in
various animal models have demonstrated that PI3K and
Akt play an important role in oocyte maturation. Previously,
it was shown that PI3K and Akt are involved in FSH-
induced meiotic maturation in mice (Hoshino et al., 2004).
In addition, data generated in a porcine animal model
suggested that PI3K activity in cumulus cells is required for
both the suppression of spontaneous meiotic resumption and
the induction of gonadotropin-stimulated meiotic resump-
tion (Shimada et al., 2003). Finally, PI3K/Akt was shown to
induce the resumption of meiosis in both Xenopus and
starfish oocytes (Andersen et al., 1998; Hiraoka et al.,
2004). Aside from its role in oocyte maturation, this signal
transduction pathway also appears to be involved in the
mechanism by which certain cytokines mediate their
antiapoptotic effects. The antiapoptotic effect of stem cell
factor on oocytes in primordial follicles was shown to
involve the PI3K/Akt signal transduction pathway (Jin et al.,
2005).
PI3K and Akt may also play a role later in the re-
productive process. Akt1 is widely expressed in murine
placenta including trophoblast and vascular endothelial
cells. Akt1 deficient mice display defects in placental
development including decreased vascularization, hypo-
trophy, an absence of glycogen-containing cells in the
spongiotrophoblast and a reduction of the decidual basalis
(Yang et al., 2003). Moreover, the PI3K/Akt pathway has
been implicated in both the differentiation and migration of
trophoblast cells (Kamei et al., 2002; Qiu et al., 2004). Thus,
taken together, these data suggest the PI3K/Akt pathway
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process and therefore may be important for reproductive
success.
The aforementioned studies characterizing the role of the
PI3K/Akt pathway during reproduction lead us to examine
whether these proteins are present and functional during
murine preimplantation development. The identification of
the presence of this pathway in preimplantation embryos
may prove important for elucidating signal transduction
pathways that are crucial for preimplantation embryo
survival and reproductive success.Materials and methods
Embryo recovery and culture
All mouse studies were approved by the Animal
Studies Committee at Washington University School of
Medicine and conform to the Guide for the Care and Use
of Laboratory Animals published by the National Institutes
of Health. Embryos were recovered as previously
described (Moley et al., 1998). Briefly, female mice (B6
X SJL F1, Jackson Laboratories, Bar Harbor, ME) 4–6
weeks of age were given free access to food and water and
were maintained on a 12 h light/dark cycle. Female mice
were superovulated with an intraperitoneal (ip) injection of
10 IU/animal of pregnant mare serum gonadotropin
(PMSG) (Sigma Chemical Co, St. Louis, MO) followed
48 h later by an ip injection of 10 IU/animal of human
chorionic gonadotropin (hCG) (Sigma Chemical Co.) and
mated with males of proven fertility. Mating was
confirmed by identification of a vaginal plug. Animals
were sacrificed at 24 (one-cell), 48 (two-cell), 54 (four-
cell), 72 (morula) or 96 (blastocyst) h post-hCG admin-
istration and mating to isolate embryos at the appropriate
stage of development. Embryos were obtained by flushing
dissected uterine horns and ostia and immediately placed
in human tubal fluid medium (HTF) (Irvine Scientific,
Irvine, CA) supplemented with 0.25% BSA (fraction V,
Sigma; St. Louis, MO). One-cell embryos were immedi-
ately placed in HTF medium containing 0.3 mg/ml
hyaluronidase (Sigma; St. Louis, MO) to remove the
cumulus cells. Further treatment of embryos for specific
experiments is described below.
Immunofluorescent staining of embryos
For localization of the PI3-kinase subunits (p85 and
p110), Akt and phospho-Akt during preimplantation devel-
opment, embryos were fixed for 20 min in 3% paraformal-
dehyde (Sigma; St. Louis, MO), permeabilized for 20 min
with 0.1% Tween-20 (Sigma; St. Louis, MO) and placed on
glass slides. All staining was performed on slides under
microdroplets in a humidified chamber at room temperature
in the dark. Fixed embryos were blocked with 20% normalgoat serum or 20% normal donkey serum in phosphate-
buffered saline (PBS) with 2% BSA for 1 h. Embryos were
immunostained with goat anti-PI3K p110 (Santa Cruz
Biotechnology, Inc.; Santa Cruz, CA), rabbit anti-PI3K
p85 (Upstate Cell Signaling Solutions; Lake Placid, NY),
rabbit anti-Akt (Akt1/2) (H-136, Santa Cruz Biotechnology,
Inc.; Santa Cruz, CA) or rabbit anti-phospho-Akt1/2/3
(serine 473) (Covance Research Products, Inc.; Berkley,
CA) at a concentration 20 Ag/ml for 1 h. After three 10 min
washes with PBS/2%BSA, an anti-rabbit or anti-goat Alexa
488 secondary antibody was added at a concentration of 2
Ag/ml (Molecular Probes, Eugene, OR) for 20 min.
Embryos were counterstained with TO-PRO\-3 iodide
(Molecular Probes; Eugene, OR) at a concentration of 4
AM for 20 min. Finally, embryos were washed 3 times in
PBS and mounted in drops of Vectashield (Vector Labo-
ratories; Burlingame, CA) under a coverslip. Fluorescence
was detected with laser-scanning confocal immunofluores-
cent microscopy (Bio-Rad MRC-600, 63 magnification)
as described previously (Moley et al., 1998). As controls,
fixed embryos were stained with control preimmune sera or
affinity-purified whole IgG. All experiments were per-
formed at least three times with representative experiments
presented.
Embryo Western blot analysis
An average of 75 embryos were pooled, added directly
to Laemmli sample buffer, subjected to SDS-PAGE and
transferred to nitrocellulose. Blots were blocked for 1 h at
RT in 5% milk in TBS-T. The blots were probed overnight
at 4-C in 1% milk in TBS-T with the following antibodies
as indicted in the figure legends: rabbit anti-PI3-kinase p85
(1 Ag/ml) (Upstate, Lake Placid, NY); rabbit anti-p-Akt
(Ser 473) 0.5 Ag/ml (Covance Research Products, Inc.;
Berkley, CA); and mouse anti-actin (1:1000) (Chemicon
International Inc.; Temecula, CA). Blots were washed 3
times for 10 min each with TBS-T. The appropriate HRP-
conjugated secondary antibody (either goat anti-rabbit or
goat anti-mouse) at a dilution of 1:10,000 was used for
detection (Santa Cruz Biotechnology, Santa Cruz, CA) and
visualized using SuperSignal\ West Dura following the
manufacturer’s instructions (Pierce; Rockford, IL).
To determine if Akt was activated in response to
insulin stimulation, blastocysts were recovered as
described above and then immediately incubated for 30
min in HTF/BSA or HTF/BSA supplemented with 1 AM
insulin (Sigma; St. Louis, MO). Blastocysts were then
rinsed in HTF only and stored at 80-C until Western
blot analysis was performed. To demonstrate the effect of
LY-294002 on the phosphorylation status of Akt, blasto-
cysts were harvested as described above and cultured in
either DMSO (vehicle control) or 250 AM LY-294002 for
15 or 30 min and subsequently subjected to Western blot
analysis. These experiments were conducted at least three
times each.
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To examine the physiologic function of the PI3K/Akt
pathway in the blastocyst, embryos were exposed to PI3K
inhibitors, and IGF-1/insulin-stimulated glucose uptake was
assessed. Nonradioactive insulin-stimulated 2-deoxyglucose
uptake into single blastocysts was performed using micro-
fluorometric assays combined with enzymatic cycling
reactions as previously described (Moley et al., 1998).
Briefly, embryos were cultured for 10 min in HTF only,
HTF supplemented with 250 AM LY-294002 or HTF
supplemented with 100 nM Wortmannin (Sigma; St. Louis,
MO). Next, blastocysts from each condition were incubated
in HTF media at a final glucose concentration of 5.6 mM
with 500 nM insulin (Sigma, bovine pancreas) for 30 min.
2-Deoxyglucose uptake was then measured as described
previously (Moley et al., 1998).
Blastocyst hatching
Blastocysts were harvested and subsequently cultured in
vitro at 37-C under 5% CO2 in plates containing 30 Al
droplets of HTF medium under oil. A total of ten unhatched
blastocysts were placed in each droplet. The droplets
contained HTF plus DMSO (vehicle control) or 250 AM
LY-294002. Blastocyst hatching was examined after 24 h in
culture using phase-contrast microscopy. A minimum of 100
blastocysts was examined per treatment group over the
course of three independent experiments.
Trophoblast stem (TS) cell culture
Primary TS cells were a generous gift from Dr. Leonidas
Carayannopoulos (Washington University, St. Louis MO)
and were generated from C57/B6 mice following published
protocols (Tanaka et al., 1998). To confirm the trophoblast
lineage of this cell line, several genetic markers were
analyzed. These markers included two TS specific genes,
Errb and Hand1, which were both expressed in this cell line,
one embryonic stem (ES) cell specific marker, Oct3/4, which
was not expressed in this cell line, and one mesoderm
specific gene, Brachyury, which was not expressed in this
cell line. In addition, this TS line was able to differentiate to
become Placental lactogen 1 (PL-1) positive, a marker of
giant cells. TS lines were maintained in the absence of mouse
embryonic fibroblast (MEF) feeder layers, cultured instead
in the presence of MEF conditioned media (MEF-CM).
MEF-CM was generated by culturing 2  106 irradiated
MEFs (5000 rads) per 10 cm dish in TS media [RPMI
(Cambrex Bio Science; Walkersville, MD), 20% FBS
(Hyclone; Logan, UT), 1 mM sodium pyruvate (Cambrex
Bio Science; Walkersville, MD), 100 AM h-mercaptoethanol
(Sigma; St. Louis, MO) and 2 mM l-glutamine (Cambrex
Bio Science; Walkersville, MD)] for 72 h. Medium was spun
down to remove floating cells and debris, filtered (0.2 Am)
and frozen in 50 ml aliquots at 20-C. TS cells were thencultured in 70% MEF-CM and 30% TS medium supple-
mented with 25 ng/ml fibroblast growth factor-4 (FGF-4)
(Sigma; St. Louis, MO) and 1 Ag/ml heparin (Sigma; St.
Louis, MO).
To identify the presence of the PI3K p85 subunit, Akt
and p-Akt in the TS cells, 2  106 cells were cultured as
described above and lysed in a buffer containing 50 mM
Tris pH 8.0, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA
and protease inhibitors. 10 Ag of protein was loaded per
lane as determined by the BCA protein assay (Pierce;
Rockford, IL) and subsequently subjected to Western blot
analysis. All antibody concentrations and Western blot
conditions were the same as described for Western blot
analysis of embryos. To demonstrate the effect of LY-
294002 on the phosphorylation status of Akt, 2  106 TS
cells were cultured in either DMSO or 250 AM LY-294002
for 15, 30 or 60 min and subsequently subjected to
Western blot analysis.
Statistical analysis
For evaluation of differences in IGF-1/insulin-stimulated
2-deoxyglucose uptake, ANOVA was utilized with a Fisher
post-hoc test. An unpaired t test was used for the analysis
of the in vitro hatching experiments. Results are expressed
as means T standard error of at least three separate
experiments.Results
PI3-kinase and Akt expression in preimplantation
development
To date, there are no data showing the expression of
phosphatidylinositol 3-kinase (PI3K) in the mammalian
preimplantation embryo. In order to elucidate the presence
of this kinase at this early stage of development, we first
performed immunofluorescent staining on preimplantation
embryos from a one-cell to a blastocyst stage (Fig. 1).
PI3K is a heterodimeric enzyme composed of an 85 kDa
regulatory subunit and an 110 kDa catalytic subunit. Fig.
1 illustrates the expression of both subunits of this kinase
at all stages of preimplantation development. Both
subunits are predominantly localized to the plasma
membrane (PM) of cleavage stage embryos. During this
period, these proteins were also detected in the cytoplasm
of the developing embryo. At the blastocyst stage, the p85
and p110 subunits are largely expressed on the apical
surface of the trophectoderm (TE). Thus, both PI3K
subunits are expressed throughout murine preimplantation
development.
The best characterized downstream target of PI3K is the
serine–threonine kinase, Akt, a well-known mediator of
survival signals. Similar to PI3K, its expression in the
mammalian preimplantation embryo has not been charac-
Fig. 1. Detection of PI3K subunits, p85 and p110, in preimplantation
embryos. Preimplantation mouse embryos were retrieved at different stages
of development and stained with either preimmune antisera as a negative
control or with antibodies specific for the p85 or p110 subunit of PI3K. The
embryos were then incubated with a secondary antibody, Alexa Fluor 488
goat anti-rabbit or donkey anti-goat IgG (green fluorescence). Embryos
were counterstained with TO-PRO-3 iodide, which stains nuclei (blue
channel). Fig. 2. Immunofluorescent staining of Akt and phospho-Akt. Preimplan-
tation mouse embryos were retrieved at different stages of development
and stained with antibodies specific for Akt (Akt1/2) or p-Akt (Ser 473).
The embryos were then incubated with a secondary antibody, Alexa Fluor
488 goat anti-rabbit (green channel). Embryos were counterstained with
TO-PRO-3 iodide, which stains nuclei (blue channel).
Fig. 3. Detection of the PI3K p85 subunit, Akt and p-Akt in preimplantation
blastocyst by Western blot analysis. An average of 75 blastocyst stage
embryos/well were added to Laemmli sample buffer and then subjected to
SDS-PAGE and Western blot analysis. The membranes were probed with
preimmune sera or antibodies specific for p85, Akt (Akt 1/2) or p-Akt.
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embryos using an antibody specific for Akt1 and Akt2 was
utilized to determine the presence and expression pattern of
this protein. As seen for PI3K, Akt is expressed at all stages
of development and appears to be expressed predominantly
at the PM (Fig. 2). Again, at the blastocyst stage, Akt
displays an apical pattern of expression on the TE. As shown
in Fig. 2, phosphorylated Akt is detected throughout murine
preimplantation development, and its presence at the plasma
membrane is a reflection of its activation status. Protein
expression of the PI3K subunits, Akt, and the phosphory-
lation status of Akt were confirmed by Western blot analysis
of blastocyst stage embryos (Fig. 3).
Akt is activated in response to insulin
In order to determine if preimplantation embryos respond
to growth factor stimulation by activating Akt, blastocysts
were cultured in the presence of insulin and analyzed for an
increase in Akt phosphorylation as compared to untreated
control embryos. As depicted in Fig. 4, there is an average
2-fold increase in the amount of phosphorylated Akt in
embryos stimulated with insulin. This confirms that the
PI3K/Akt pathway is active at this early stage of develop-
ment. To further characterize this pathway in preimplanta-
Fig. 5. Akt phosphorylation is inhibited by LY-294002 in the preimplanta-
tion blastocyst. Blastocysts were harvested and cultured in either DMSO
(vehicle control) or 250 AM LY-294002 for 15 or 30 min and subsequently
subjected to SDS-PAGE and Western blot analysis. The membranes were
probed with an antibody specific for p-Akt and actin.
Fig. 6. Insulin-stimulated glucose uptake is inhibited by LY-294002 and
Wortmannin. Insulin-stimulated glucose uptake was measured in blastocysts
exposed to media alone (no treatment), 250 AM LY-294002 and 100 nM
Wortmannin. The percent insulin-stimulated glucose uptake over basal
glucose uptake is plotted. Embryos exposed to media alone demonstrated a
15.9% T 1.2% increase in glucose uptake, while those blastocysts exposed to
PI3K/Akt inhibitors demonstrated no increase in glucose uptake in response
to insulin with a slight decrease in basal uptake (LY-294002  10.7% T
3.9%; Wortmannin  5.3% T 6.6%) (*P < 0.05).
Fig. 4. Preimplantation embryos respond to insulin stimulation by
activating Akt. (A) 75 blastocyst stage embryos were retrieved and
immediately incubated for 30 min in HTF/BSA or HTF/BSA supplemented
with 1 AM insulin. The embryos were added to Laemmli sample buffer and
then subjected to SDS-PAGE and Western blot analysis. The membranes
were probed with antibodies specific for p-Akt and actin. This experiment
was performed in triplicate with a representative blot presented here. (B)
Western blots were quantitated using densitometry and NIH image
software, and expression was normalized to actin. The average expression
of p-Akt after insulin stimulation was 217% T 54% compared to untreated
control embryos.
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the PI3K inhibitor, LY-294002. After only 15 min, Akt
phosphorylation was inhibited (Fig. 5), again confirming
that this pathway responds as expected to environmental
cues in preimplantation embryos.
Insulin-stimulated glucose uptake is blocked in the presence
of PI3K/Akt inhibitors
Insulin and IGF-1 stimulate glucose uptake in the
preimplantation blastocyst specifically via the IGF-1R
(Harvey and Kaye, 1991). Since PI3K activity is directly
downstream of IGF-1 receptor phosphorylation in most cell
types, we hypothesized that PI3K activity may be involved
in IGF-1/insulin-stimulated glucose uptake in the blastocyst.
To test this hypothesis and to determine the physiologic role
of the PI3K/Akt pathway, we analyzed the effect of inhibitors
of this pathway on insulin-stimulated glucose uptake in the
blastocyst. Exposure of blastocyst stage embryos to the PI3K
inhibitors LY-294002 and Wortmannin resulted in the
complete inhibition of insulin-stimulated glucose uptake.
As shown in Fig. 6, control embryos showed a significant
increase in glucose uptake when exposed to insulin. This was
in contrast to blastocysts cultured in the presence of eitherLY-294002 or Wortmannin, in which insulin-stimulated
glucose uptake was completely inhibited.
Inhibition of the PI3K/Akt pathway results in decreased
blastocyst hatching
In mice, the blastocyst hatches from the zona pellucida
during the fifth day of development (Nagy et al., 2003).
Embryo hatching is required for successful implantation
(Hartshorne and Edwards, 1991). To determine whether the
PI3K/Akt pathway plays a role in this critical developmental
process, we cultured embryos in LY-294002 and determined
the percentage of blastocysts hatching at a 24-h time point
as compared to controls (Fig. 7). The percentage of
blastocysts hatching was 41% T 3.0% of embryos cultured
in DMSO (vehicle control) as compared to 23% T 3.5% of
blastocysts cultured in LY-294002 (P < 0.02). Thus,
Fig. 7. LY-294002 inhibits blastocyst hatching. Blastocysts were harvested
and subsequently cultured in vitro in either DMSO (vehicle control) or 250
AM LY-294002 for 24 h. The percentage of blastocysts hatching after 24 h
in culture was 41% T 3.0% of embryos cultured in DMSO as compared to
23% T 3.5% of blastocysts cultured in LY-294002 ( P < 0.02). A minimum
of 100 blastocysts were examined per treatment group over the course of
three independent experiments.
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in decreased blastocyst hatching.
PI3K/Akt pathway is present and functional in trophoblast
stem (TS) cells
In an effort to develop an in vitro cell culture system
to serve as a model to study the PI3K/Akt pathway in the
developing embryo, we characterized the expression and
function of PI3K and Akt in trophoblast stem (TS) cells.
TS cells are derived from the trophectoderm of mouse
blastocysts and possess the capacity to develop into each
of the four trophoblast cell lineages (Tanaka et al., 1998).
Based on the localization of the PI3K subunits and Akt at
the apical surface of the TE in the blastocyst, we believe
that the TS cell line would be an ideal in vitro correlate
for our studies. As shown in Fig. 8A, the regulatory
subunit of PI3K, p85 and Akt is expressed in TS cells.
Similar to what was seen in the preimplantation embryo,
Akt was constitutively phosphorylated in the TS cells. In
addition, exposure of these cells to the PI3K inhibitor,
LY-294002, resulted in the inhibition of Akt phosphor-
ylation (Fig. 8B). Taken together, these results recapitulate
what was found in vivo and provide a cell culture system
to further characterize this pathway during preimplantation
embryonic development.Fig. 8. The PI3K/Akt pathway is present and functional in trophoblast stem
(TS) cells. (A) 2  106 TS cells were lysed and then subjected to SDS-
PAGE and Western blot analysis. 10 Ag of protein was loaded per lane. The
membranes were probed with preimmune sera or antibodies specific for
p85, Akt or p-Akt. (B) TS cells were cultured in either DMSO or 250 AM
LY-294002 for 15, 30 or 60 min and subsequently subjected to Western blot
analysis. 10 Ag of protein was loaded per lane. The membranes were probed
with an antibody specific for p-Akt and actin.Discussion
The preimplantation stage of development is unique in a
number of significant ways. Prior to implantation, the
developing embryo is a free floating entity, dependent on
autocrine and maternally derived paracrine growth factors
for its development. While much is known about signaling
pathways that regulate the earliest stages of development ina number of model systems, less is known about the
preimplantation period in mammals. In particular, the
maternal environment remains ill defined as do the factors
that drive these very first stages of development.
Gaining a greater understanding of this stage of
development and what growth factors and signaling path-
ways are utilized are of particular interest in light of the
growing field of assisted reproductive technology (ART).
Human embryos are routinely manipulated from a one-cell
to a blastocyst stage in culture conditions that may or, more
likely, may not closely resemble the in vivo environment. In
vitro culture can perturb embryo metabolism and gene
expression, the long-term consequences of which are
unknown. There is mounting evidence to suggest that,
while not overt, offspring generated from in vitro fertiliza-
tion may display developmental and neurological abnor-
malities (Hansen et al., 2002; Schieve et al., 2002;
Stromberg et al., 2002). It is well documented in the field
of animal husbandry that offspring generated from embryos
exposed to in vitro environments often results in unusually
large offspring, referred to as ‘‘large offspring syndrome’’
(Young et al., 1998). In a recent human study, ART was
shown to be associated with an increase in the prevalence
of the human outgrowth syndrome, Beckwith–Wiedemann
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from embryos cultured in vitro exhibited significant
cognitive deficits as compared to control animals (Ecker
et al., 2004). It is for these reasons that it is critical to
understand how early development is regulated and how
perturbations in this environment can have long-term
detrimental consequences.
In this manuscript, we established the presence and
functionality of the PI3K/Akt pathway during murine
preimplantation embryo development. The PI3K/Akt signal-
ing proteins are expressed at all stages of preimplantation
development. Based on immunofluorescent imaging of
embryos, these proteins appear to be predominantly
localized to the PM, suggesting constant stimulation of this
pathway during the preimplantation period. Presumably,
maternal- and/or embryo-derived growth factors are respon-
sible for this ongoing activation. At the blastocyst stage of
development, we demonstrate that this pathway is function-
ally active as shown by the increased phosphorylation of
Akt in response to insulin stimulation. Additionally, we
were able to inhibit this response with the PI3K inhibitor,
LY-294002.
Insulin and IGF-1 stimulate glucose uptake in the
preimplantation blastocyst via activation of the IGF-1R
(Harvey and Kaye, 1991). Previous work from our
laboratory has shown that down-regulation of the IGF-1R
results in the inhibition of insulin-stimulated glucose uptake
(Chi et al., 2000). It was concluded from these studies that
the defect resulting in the inhibition of glucose uptake was a
direct result of the decreased downstream signaling from the
IGF-1R. Data presented here confirm that the IGF-1R is
upstream of PI3K/Akt and that insulin-stimulated glucose
uptake is PI3K-dependent at the blastocyst stage of
development, similar to what is found in adult muscle and
adipose tissue. Recently, Gross et al. (2005) have demon-
strated another possible physiologic consequence of the
PI3K pathway by showing that inhibition of this pathway
leads to ES cell and blastocyst apoptosis. These experi-
ments, however, were performed under serum-free con-
ditions, which alone can induce apoptosis. Under
physiologic conditions, other growth factors, either present
in the embryo’s milieu or produced by the embryo itself,
may compensate for changes in PI3K activity. These
findings suggest that withdrawal of growth factors and
decreased signaling via the PI3K/Akt pathway may trigger
apoptosis as shown in cell systems such as neurons and
lymphocytes (Pierchala et al., 2004; Plas et al., 2002).
Further studies are necessary to elucidate the physiologic
consequences of PI3K/Akt inhibition and the mechanisms
involved.
Importantly, we demonstrated a developmental conse-
quence of the PI3K/Akt pathway by showing that inhibition
of this pathway leads to decreased blastocyst hatching
which is required for successful implantation of the embryo.
Previous studies have identified factors that affect mouse
embryo hatching. Huang et al. demonstrated that COX-2-derived prostacyclin increases mouse embryo hatching. A
COX-2 inhibitor was shown to inhibit embryo hatching;
however, this inhibition was reversed if iloprost, a prosta-
cyclin analogue, was also added to the media (Huang et al.,
2004). The mechanism by which inhibition of the PI3K/Akt
pathway results in decreased blastocyst hatching remains
unclear. However, recent studies have demonstrated that the
PI3K/Akt pathway may regulate COX-2 expression at least
in certain cell lines (Sheng et al., 2001; Tang et al., 2001;
Weaver et al., 2001). Whether or not inhibition of PI3K in
the embryo has an affect on COX-2 expression and thus
embryo hatching remains to be determined.
The PI3K/Akt pathway is a well-known mediator of
growth promoting and cell survival signals. Evidence
suggests that PI3K-generated phospholipids regulate Akt
activity by directly binding to its PH domain (Franke et al.,
1997). A consequence of Akt binding to phospholipids is
the translocation of Akt from the cytoplasm to the inner
surface of the plasma membrane (Currie et al., 1999).
Relocalization of Akt to the PM brings Akt into proximity
of regulatory kinases that phosphorylate and activate Akt.
Interestingly, at the blastocyst stage, the point at which the
first differentiation step has occurred and two cell types,
the ICM and TE, are present, PI3K and Akt localize to the
PM of the apical trophectoderm. It is this cell layer that
directly interacts with the maternal environment and is
responsible for transferring external stimuli into the
developing embryo.
The localization of the PI3K/Akt signaling molecules to
the TE of the blastocyst led us to investigate the presence of
this pathway in trophoblast stem (TS) cells, potentially
providing us with an in vitro cell line to study this pathway
in embryonic development. Protein expression of the
regulatory subunit of PI3K, p85 and Akt was demonstrated
by Western blot analysis of TS cell lysates. Similar to what
was seen during preimplantation embryo development, Akt
was constitutively phosphorylated in the TS cells. More-
over, the PI3K inhibitor, LY-294002, abrogated constitutive
Akt phosphorylation. Our results are similar to what was
shown in a previous study, which characterized the role of
the PI3K/Akt pathway in the differentiation of trophoblast
cells (Kamei et al., 2002). This group found, as we did, that
Akt is constitutively active in TS cells. In addition, they
were able to show that there was an increase in Akt
phosphorylation when the cells were forced to differentiate.
Taken together, these data are the first to demonstrate that
the PI3K/Akt pathway is present and functional at this early
stage in development.
This manuscript provides a comprehensive analysis of
the presence and function of the PI3K/Akt signaling
pathway during preimplantation development. The data
establish the role of this pathway in IGF-1-receptor-
regulated glucose uptake as well as in blastocyst hatching
to facilitate implantation. Further analysis is underway to
determine how physiologic perturbations in this pathway
affect the developing embryo.
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